Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) CEO Matt Stang was included in World Biz magazine’s Top-100 CEOs in Innovation for 2022. The announcement noted that Stang was recognized as a champion of creativity who is dedicated to making a positive environmental and social impact. Stand cofounded Delic Corp., which has grown into a leader in new medicines and treatments for a modern world. Stang led the company’s acquisition of the Ketamine Wellness Centers, and under his guidance, the company reported more than $1.5 million in total revenue in 2021 while more than quadrupling its net assets. This month, Stang transitioned from Delic CEO to executive chair, where he will continue to focus on the company’s mission of revolutionizing healthcare. “It is an honor to be recognized by World Biz magazine as one of the foremost innovators in healthcare today,” said Delic Holdings executive chair Matt Stang in the press release. “With the help of my talented team at Delic Corp, we continue to make safe, affordable treatments more accessible to patients across the country. I firmly believe that our company’s work is bettering the lives of people and communities every day. I am proud to be a part of this team and am truly excited to see what the future holds.”
The company also announced that it has postponed its exclusive Meet Delic Conference, which was originally scheduled for Nov. 5–6, 2022, in Las Vegas. Delic announced that the premier event is now slated for Oct. 14–15, 2023; the location will remain Las Vegas and tickets that have already been purchased for this year’s event will be honored for next year’s gathering. According to the announcement, Delic’s Meet Delic is the world’s premier psychedelic wellness experience. The event includes programs, activities, talks, panels and discussions — all centered on an aspect of psychedelics and presented by thought and business leaders as well as health & wellness experts. “Meet Delic 2021 was the first event of its kind and brought awareness to the benefits of psychedelics to heal people and communities through enlightening panels and talks and electrifying performances,” said Stang. “Next year promises to be a breakthrough year for the psychedelic renaissance, so we’ve decided the best way to celebrate is to move Meet Delic to 2023.”
To view the full press releases, visit https://ibn.fm/3Q0o9 and https://ibn.fm/r9CP1
About Delic Holdings
Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics. The company owns and operates an umbrella of related businesses, including Ketamine Wellness Centers, the largest chain of psychedelic wellness clinics in the country; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premier psychedelic wellness event; and trusted media and e-commerce platforms Reality Sandwich and Delic Radio. Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products and effective treatment options to the masses. For more information about the company, visit www.DelicCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
